| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Thilo Schroeder last filed a Form 4 in December 2024, as Director at SPRY. The filings on record cover 3 companies. From February 2020 to December 2024, the filings on record show 10 open-market purchases and 27 sales. Thilo Schroeder's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Thilo Schroeder a strong insider score of 80/100, based on 82 past trades. Over a 12-month horizon, 93.9% of those trades were profitable, with an average 12-month return of +43.0%.
At the last filing, the largest reported position was 760,869 shares of RVMD. Net of sales, the RVMD filings show accumulation of 4,025,662 shares.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 68,480 | $34.36 | $2,352,993.04 | -3.8% | -29.5% | -50.6% | |
| Aug 9, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 77,693 | $36.23 | $2,814,961.08 | -4.1% | -30.0% | -55.6% | |
| Aug 4, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 96,136 | $35.05 | $3,369,931.96 | -4.8% | -34.1% | -55.4% | |
| Jul 29, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 11,024 | $35.75 | $394,149.24 | -0.6% | -32.3% | -57.1% | |
| Jul 27, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 17,362 | $35.91 | $623,516.82 | -0.9% | -27.9% | -53.9% | |
| Jul 22, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 18,872 | $35.82 | $675,953.04 | -0.9% | -31.2% | -60.2% | |
| May 28, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 5,100 | $35.80 | $182,580.00 | -0.2% | -13.3% | -55.4% | |
| May 26, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 16,005 | $35.79 | $572,867.80 | -0.8% | -11.2% | -62.7% | |
| May 24, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 44,780 | $35.92 | $1,608,560.16 | -2.1% | -14.6% | -60.9% | |
| May 10, 2021 | PMVP Pmv Pharmaceuticals, Inc. | Director | Sell | 1,787 | $35.67 | $63,742.29 | - | +1.7% | -62.2% |